Emergent Biosolutions Inc (EBS)
EBITDA Margin
-56.47%
Quarterly · Period ending:
EBS EBITDA Margin
Latest reported-56.47%period ending
Latest reported-56.47%period ending
EBS Quarterly EBITDA Margin (-19.69% → -56.47%)
Quarterly ebitda margin
High-resolution chart · PNG
EBS ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -56.4661% | |
| 30.6855% | |
| -8.4062% | |
| 41.627% | |
| 15.1881% | |
| 59.766% | |
| 11.1454% | |
| 33.4922% | |
| -51.276% | |
| 21.4048% | |
| -4.5553% | |
| 9.0203% | |
| 14.4717% | |
| -62.6902% | |
| 11.6899% | |
| -5.2105% | |
| -12.5052% | |
| 12.2927% | |
| 48.2024% | |
| -0.3343% | |
| 12.327% | |
| 36.5015% | |
| 49.2967% | |
| 30.919% | |
| 39.169% | |
| 8.9351% | |
| 32.2725% | |
| 31.5587% | |
| 8.8405% | |
| -0.3148% | |
| 16.215% | |
| 19.4124% | |
| 35.9673% | |
| 2.3769% | |
| 37.2557% | |
| 39.1283% | |
| 18.517% | |
| 21.8008% | |
| 44.1373% | |
| 34.7146% | |
| 7.5492% | |
| 29.9105% | |
| 52.852% | |
| 45.2841% | |
| 45.2732% | |
| -28.5669% | |
| 41.1468% | |
| 29.0126% | |
| 14.7936% | |
| -33.7967% | |
| 37.4255% | |
| 26.1745% | |
| 22.9524% | |
| -21.3155% | |
| 25.9476% | |
| 18.9017% | |
| 17.2282% | |
| -18.4572% | |
| 44.6428% | |
| 6.6012% | |
| 25.4944% | |
| -179.3396% | |
| 35.7899% | |
| 29.7583% | |
| 24.4408% | |
| 10.3718% | |
| 10.8022% | |
| -5.4285% | |
| 33.1325% | |
| 29.1449% | |
| 6.3524% | |
| 27.0994% | |
| 10.1046% | |
| 30.213% | |
| 49.5086% | |
| 10.132% | |
| -32.4463% | |
| -17.5174% | |
| 52.1919% | |
| 46.4644% | |
| 100% | |
| 100% | |
| -89.0404% | |
| 100% | |
| 100% | |
| 100% | |
| -237.9581% | |
| 100% | |
| 100% | |
| 100% | |
| -19.6855% | |
| -10.5471% | |
| -86.6825% | |
| 2.0813% | |
| -19.6855% |